These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15791436)

  • 21. ²¹³Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cells.
    Pickhard A; Piontek G; Seidl C; Kopping S; Blechert B; Mißlbeck M; Brockhoff G; Bruchertseifer F; Morgenstern A; Essler M
    Nucl Med Biol; 2014 Jan; 41(1):68-76. PubMed ID: 24210808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioimmunotherapy of micrometastases in lung with vascular targeted 213Bi.
    Kennel SJ; Boll R; Stabin M; Schuller HM; Mirzadeh S
    Br J Cancer; 1999 Apr; 80(1-2):175-84. PubMed ID: 10389994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxicity of breast cancer cells overexpressing HER2/neu by 213Bi-Herceptin radioimmunoconjugate.
    Zhang DY; Li Y; Rizvi SM; Qu C; Kearsley J; Allen BJ
    Cancer Lett; 2005 Feb; 218(2):181-90. PubMed ID: 15670895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiotoxicity of bismuth-213 bound to membranes of monolayer and spheroid cultures of tumor cells.
    Kennel SJ; Stabin M; Roeske JC; Foote LJ; Lankford PK; Terzaghi-Howe M; Patterson H; Barkenbus J; Popp DM; Boll R; Mirzadeh S
    Radiat Res; 1999 Mar; 151(3):244-56. PubMed ID: 10073661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry.
    Nikula TK; McDevitt MR; Finn RD; Wu C; Kozak RW; Garmestani K; Brechbiel MW; Curcio MJ; Pippin CG; Tiffany-Jones L; Geerlings MW; Apostolidis C; Molinet R; Geerlings MW; Gansow OA; Scheinberg DA
    J Nucl Med; 1999 Jan; 40(1):166-76. PubMed ID: 9935073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts.
    Yong KJ; Milenic DE; Baidoo KE; Brechbiel MW
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioimmunotherapy of human colon carcinoma xenografts using a 213Bi-labeled domain-deleted humanized monoclonal antibody.
    Milenic D; Garmestani K; Dadachova E; Chappell L; Albert P; Hill D; Schlom J; Brechbiel M
    Cancer Biother Radiopharm; 2004 Apr; 19(2):135-47. PubMed ID: 15186593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
    Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
    J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia.
    Sgouros G; Ballangrud AM; Jurcic JG; McDevitt MR; Humm JL; Erdi YE; Mehta BM; Finn RD; Larson SM; Scheinberg DA
    J Nucl Med; 1999 Nov; 40(11):1935-46. PubMed ID: 10565792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioimmunotherapy with α-particle-emitting radionuclides.
    Seidl C
    Immunotherapy; 2014; 6(4):431-58. PubMed ID: 24815783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. α-Radioimmunotherapy with ²¹³Bi-anti-CD38 immunoconjugates is effective in a mouse model of human multiple myeloma.
    Teiluf K; Seidl C; Blechert B; Gaertner FC; Gilbertz KP; Fernandez V; Bassermann F; Endell J; Boxhammer R; Leclair S; Vallon M; Aichler M; Feuchtinger A; Bruchertseifer F; Morgenstern A; Essler M
    Oncotarget; 2015 Mar; 6(7):4692-703. PubMed ID: 25576914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbicidal power of alpha radiation in sterilizing germinating Bacillus anthracis spores.
    Rivera J; Morgenstern A; Bruchertseifer F; Kearney JF; Turnbough CL; Dadachova E; Casadevall A
    Antimicrob Agents Chemother; 2014; 58(3):1813-5. PubMed ID: 24379209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 213Bi radioimmunotherapy with an anti-mCD138 monoclonal antibody in a murine model of multiple myeloma.
    Chérel M; Gouard S; Gaschet J; Saï-Maurel C; Bruchertseifer F; Morgenstern A; Bourgeois M; Gestin JF; Bodéré FK; Barbet J; Moreau P; Davodeau F
    J Nucl Med; 2013 Sep; 54(9):1597-604. PubMed ID: 24003167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid preparation of short-lived alpha particle emitting radioimmunopharmaceuticals.
    Ma D; McDevitt MR; Finn RD; Scheinberg DA
    Appl Radiat Isot; 2001 Oct; 55(4):463-70. PubMed ID: 11545498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular targeted radioimmunotherapy with 213Bi--an alpha-particle emitter.
    Kennel SJ; Mirzadeh S
    Nucl Med Biol; 1998 Apr; 25(3):241-6. PubMed ID: 9620629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoliposomal delivery of 213Bi for alpha-emitter targeting of metastatic breast cancer.
    Lingappa M; Song H; Thompson S; Bruchertseifer F; Morgenstern A; Sgouros G
    Cancer Res; 2010 Sep; 70(17):6815-23. PubMed ID: 20651254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of alpha-emitting 213Bi-labeled antibody constructs for clinical use.
    McDevitt MR; Finn RD; Ma D; Larson SM; Scheinberg DA
    J Nucl Med; 1999 Oct; 40(10):1722-7. PubMed ID: 10520715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenic expression of human metastatic prostate cancer cell lines for in vitro multiple-targeted alpha-therapy with 213Bi-conjugates.
    Li Y; Abbas Rizvi SM; Blair nee Brown JM; Cozzi PJ; Qu CF; Ow KT; Tam PN; Perkins AC; Russell PJ; Allen BJ
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):896-908. PubMed ID: 15465208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efforts to control the errant products of a targeted in vivo generator.
    Jaggi JS; Kappel BJ; McDevitt MR; Sgouros G; Flombaum CD; Cabassa C; Scheinberg DA
    Cancer Res; 2005 Jun; 65(11):4888-95. PubMed ID: 15930310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.